Dubai, UAE — 8–10 September 2026 — Genèse Labs returned to Dubai Derma at the Dubai World Trade Centre for a second consecutive year, unveiling the peptide meso line MESO PEPTA™ and the CaHA filler SofistiCa for the first time. For three days, the booth was packed with visitors from across the Middle East, Africa and South Asia.

• Second consecutive participation in Dubai Derma, following 2025

• First presentation of two new products: MESO PEPTA™ and SofistiCa

• In a Middle East market seeking contour, volume and brightening, SofistiCa, Réluma Kiss and MESO PEPTA™ Pink Code led demand

• The full 2026 line-up in one place — our busiest booth to date

Having formally entered the Middle East through Dubai Derma 2025, Genèse Labs returned a year later with two new launches. MESO PEPTA™, built on four codes for brightening, anti-ageing, lifting and scalp care, and SofistiCa, a CaHA filler combining immediate volume with collagen stimulation, were both unveiled here for the first time.

The Middle East has strong demand for defined contours, generous volume and lip treatments, alongside keen interest in a clear, even tone and scalp and hair care. Reflecting this, enquiries centred on SofistiCa, with its combination of immediate volume and regenerative action; Réluma Kiss, the lip filler that adds a natural rosy tone; and MESO PEPTA™’s Pink Code (brightening) and Scalp Code (scalp care). The RG Body Filler family for body contouring also remained in steady demand.

Alongside the two new launches, visitors could see every product introduced in 2026 in one place — NADX³ and AxeniQ™ from March and Aqua Feel from August. With visitors eager to explore a portfolio spanning fillers, toxin, skin boosters and a meso line, the booth was packed wall to wall for all three days, and distribution discussions for both new products opened in several countries.

Genèse Labs is a Paris-founded aesthetic company dedicated to science-based, regulatory-led product development across body contouring, collagen biostimulation, fillers, neuromodulators, and longevity and regenerative skincare. Since its foundation in 2019, the company has built its portfolio — including the RG Body Filler line, Proluma™ (PDLLA, PLLA and RH Collagen), Réluma, SofistiCa, AxeniQ™, NADX³, Aqua Feel, MESO PEPTA™, Citrus Bottle™, Exoluma™ (Human, Plant and Exo-PDRN) and Exo-Mask — on three principles: scientifically verifiable formulations, regulatory compliance in every market entered, and continuous engagement with the international clinical and academic community. Genèse Labs partners with dermatologists, aesthetic physicians and distributors worldwide to advance the standard of modern aesthetic medicine. For more information: www.geneselabs.net.